首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: A multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)
【24h】

Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: A multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)

机译:估计的GFR报告对晚期肾病患者的晚期转诊率和实践模式的影响:使用澳大利亚和新西兰透析与移植注册中心(ANZDATA)进行的多级logistic回归分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background Late referral for renal replacement therapy (RRT) leads to worse outcomes. In 2005, estimated glomerular filtration rate (eGFR) reporting began in Australasia, with an aim of substantially increasing earlier disease detection. Study Design Observational cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) data. Setting & Participants All patients commencing RRT in Australasia between January 1, 1999, and December 31, 2010. We excluded the period between December 31, 2004, and January 1, 2007, to allow for practice change. Factor Introduction of eGFR reporting. Outcomes Primary outcome was late referral defined as commencing RRT within 3 months of nephrology referral. Secondary outcomes included initial RRT modality and prepared access at hemodialysis therapy initiation. Measurements Late referral rates per era were determined and multilevel logistic regression was used to identify late referral predictors. Results We included 25,009 patients. Overall, 3,433 (25.3%) patients were referred late in the pre-eGFR era compared with 2,464 (21.6%) in the post-eGFR era, for an absolute reduction of 3.7% (95% CI, 2.7%-4.8%; P < 0.001). After adjustments for age, body mass index, race, comorbid conditions, and primary kidney disease, adjusted late referral rates were 25.8% (95% CI, 23.3%-28.3%) and 21.8% (95% CI, 19.2%-24.4%) in the pre- and post-eGFR eras, respectively, for a difference of 4.0% (95% CI, 1.2%-6.8%; P = 0.005). Late referral risk was attenuated significantly post-eGFR reporting (OR, 1.30; 95% CI, 1.12-1.51) compared to pre-eGFR reporting (OR, 2.15; 95% CI, 1.88-2.46) for indigenous patients. Late referral rates decreased for older patients but increased slightly for younger patients (P = 0.001 for interaction between age and era). There was no impact on initial RRT modality or prepared access rates at hemodialysis therapy initiation between eras. Limitations Residual confounding could not be excluded. Conclusions eGFR reporting was associated with small reductions in late referral, but more than 1 in 5 patients are still referred late. Other initiatives to increase timely referral warrant investigation.
机译:背景晚期转诊接受肾脏替代治疗(RRT)会导致预后不良。 2005年,在澳大利亚开始估计肾小球滤过率(eGFR)的报告,目的是大大提高早期疾病的检测率。研究设计使用澳大利亚和新西兰透析与移植注册中心(ANZDATA)数据进行的队列研究。设置和参与者1999年1月1日至2010年12月31日期间在澳大拉西亚所有开始RRT的患者。我们排除了2004年12月31日至2007年1月1日之间的时间,以便进行实践更改。 eGFR报告的要素介绍。结局主要结局是晚期转诊,定义为肾脏科转诊3个月内开始RRT。次要结果包括最初的RRT方式以及在血液透析治疗开始时的准备使用方法。测量确定每个时代的后期推荐率,并使用多级逻辑回归来确定后期推荐预测因子。结果我们纳入了25,009名患者。总体而言,在eGFR前时代转诊的患者为3,433(25.3%),而eGFR后时代为2,464(21.6%),绝对减少了3.7%(95%CI,2.7%-4.8%; P <0.001)。在调整了年龄,体重指数,种族,合并症和原发性肾脏疾病之后,调整后的延迟转诊率为25.8%(95%CI,23.3%-28.3%)和21.8%(95%CI,19.2%-24.4%) )在eGFR之前和之后的时代分别有4.0%的差异(95%CI,1.2%-6.8%; P = 0.005)。与本地患者的eGFR之前报告(OR,2.15; 95%CI,1.88-2.46)相比,eGFR报告后的晚期转诊风险显着降低(OR,1.30; 95%CI,1.12-1.51)。老年患者的延迟转诊率降低,而年轻患者的延迟转诊率略有提高(年龄与年龄之间的相互作用,P = 0.001)。在两个时代之间开始进行血液透析治疗时,对初始RRT方式或准备的进入率没有影响。局限性不能排除残余混杂因素。结论eGFR报告与晚期转诊的小幅减少相关,但仍有超过五分之一的患者转诊较晚。其他增加及时转介手令调查的举措。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号